4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-13-033376
CIK 0001009356operating
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:23 PM ET
Size
9.9 KB
Accession
0001209191-13-033376
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Gift
Common Stock
2013-06-10+247,761.2→ 955,573.2 total - Gift
Common Stock
2013-06-10−400,000→ 0 total(indirect: by GRAT)
Holdings
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying)
Footnotes (1)
- [F1]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:23 PM ET
- Size
- 9.9 KB